Vicore Pharma Holding AB

VCRE Stock Healthcare Biotechnology
$8.98
-0.11 (-1.21%)
Price as of Oct 16, 2026 market close

Performance

1 Month
-13.7%

Price return, based on split- and dividend-adjusted closing prices.

Risk

Largest decline max drawdown, since Aug 2026
-33.0%

Own VCRE?

See how VCRE contributes to your portfolio's return, allocation, and risk.

7-day free trial, then $9/month.